» Articles » PMID: 12898248

Disruption of the Integrity of Human Peritoneal Mesothelium by Interleukin-1beta and Tumor Necrosis Factor-alpha

Overview
Journal Virchows Arch
Date 2003 Aug 5
PMID 12898248
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory and neoplastic disease processes of the abdominal cavity are frequently associated with disruption of the integrity of the peritoneal mesothelium. In the present study, we analyzed the effects of the pro-inflammatory cytokines interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) on the morphology and expression of adhesion molecules of human peritoneal mesothelial cells (HPMC). Treatment of HPMC with IL-1beta and TNF-alpha resulted in a time- and dose-dependent alteration of the normal cobblestone morphology of the mesothelium with loss of polarization, cellular retraction and exposure of the submesothelial matrix. The effect was already observable after 6 h of treatment and was most pronounced at a dose of 10 ng/ml of IL-1beta or TNF-alpha. These morphological alterations were associated with a significant rearrangement of the expression of mesothelial adhesion molecules as detected by flow cytometry. IL-1beta and TNF-alpha both led to a loss of the expression of the hemidesmosomal integrin subunits alpha6 ( P<0.01 and P<0.001) and beta4 ( P<0.01) and an increased expression of the integrin subunit alpha5 ( P<0.001 and P<0.01). IL-1beta furthermore upregulated the expression of the integrin subunits alpha1, alpha2 and the adhesion molecule CD44 while the latter was downregulated by TNF-alpha. Our data indicate that IL-1beta and TNF-alpha may significantly affect disease processes of the abdominal cavity by their potential to disrupt the mesothelial basal cell-matrix adhesion and, thus, the integrity of the peritoneal mesothelial cell lining.

Citing Articles

The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone.

Ritch S, Noman A, Goyeneche A, Telleria C Cancer Cell Int. 2022; 22(1):397.

PMID: 36494669 PMC: 9733158. DOI: 10.1186/s12935-022-02822-5.


Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion.

Estermann M, Huang Y, Septiadi D, Ritz D, Liang C, Jacob F PLoS One. 2020; 15(12):e0241500.

PMID: 33270665 PMC: 7714103. DOI: 10.1371/journal.pone.0241500.


Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.

van Baal J, van Noorden C, Nieuwland R, Van de Vijver K, Sturk A, van Driel W J Histochem Cytochem. 2017; 66(2):67-83.

PMID: 29164988 PMC: 5794203. DOI: 10.1369/0022155417742897.


Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma.

Wang R, Luo Y, Yang S, Lin J, Gao D, Zhao Y Sci Rep. 2016; 6:33844.

PMID: 27653258 PMC: 5032118. DOI: 10.1038/srep33844.


Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis.

Liu J, Geng X, Li Y Tumour Biol. 2016; 37(5):5715-26.

PMID: 26831659 PMC: 4875158. DOI: 10.1007/s13277-016-4887-3.


References
1.
Bittinger F, Schepp C, Brochhausen C, Lehr H, Otto M, Kohler H . Remodeling of peritoneal-like structures by mesothelial cells: its role in peritoneal healing. J Surg Res. 1999; 82(1):28-33. DOI: 10.1006/jsre.1998.5449. View

2.
Kutteh W, Kutteh C . Quantitation of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in the effusions of ovarian epithelial neoplasms. Am J Obstet Gynecol. 1992; 167(6):1864-9. DOI: 10.1016/0002-9378(92)91788-c. View

3.
Cronauer M, Stadlmann S, Klocker H, Abendstein B, Eder I, Rogatsch H . Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1. Am J Pathol. 1999; 155(6):1977-84. PMC: 1866924. DOI: 10.1016/S0002-9440(10)65516-2. View

4.
Cannistra S, Kansas G, Niloff J, DeFranzo B, Kim Y, Ottensmeier C . Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res. 1993; 53(16):3830-8. View

5.
Goodison S, Urquidi V, Tarin D . CD44 cell adhesion molecules. Mol Pathol. 2000; 52(4):189-96. PMC: 395698. DOI: 10.1136/mp.52.4.189. View